The Parker Institute for Cancer Immunotherapy enables real collaboration, accelerating ambitious research to deliver new immunotherapies engineered to save lives.
World-renowned experts from leading cancer centers are at the forefront of our research.
Open in Twitter Parker Institute for Cancer Immunotherapy @parkerici .@UCLAJCCC is pioneering a CAR T clinical trial in #lymphoma & #leukemia co-led by PICI researcher Yvonne Chen. The… https://t.co/rZ8Van16XE 17 hours ago
Open in Twitter Parker Institute for Cancer Immunotherapy @parkerici "The old goal of research — to find a one-size-fits-all treatment for a disease...must radically change to further… https://t.co/mi6XbXMr0W 3 days ago